| Authors: |
Almeida M; Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy., Salvadori M; Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy. Electronic address: m.salvadori@chiesi.com., Corradi M; Department of Medicine and Surgery, University of Parma, Parma, Italy., De Ridder T; Clinical Pharmacology Unit, SGS Belgium NV, Edegem, Belgium., Praet N; Clinical Pharmacology Unit, SGS Belgium NV, Edegem, Belgium., Viaud I; Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy., Varoli G; Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy., Girardello L; Alira Health Srl, Milan, Italy., Cappellini G; Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy., Viganò LV; Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy., Mathews KS; Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy., Poli G; Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy. |